Skip to main content
. 2018 Nov;20(6):789–801. doi: 10.1016/j.jmoldx.2018.06.005

Table 2.

Exons Were Categorized as Clinically Significant, Uncertain Significance, Clinically Insignificant, or Noncoding on the Basis of the Pieces of Evidence Listed

Exon designation (in genes with a clinical validity of at least moderate) Evidence used for designation
Clinically significant exon • Evidence that exon is required for biological function (eg, literature, absence of high frequency LoF variant in general population)
 AND/OR
• No alternative splicing
Exon of uncertain significance • No expression data in the literature
 AND
• Alternative splicing
 AND/OR
• 1 High-frequency LoF variant in gnomAD (>0.3%)
Clinically insignificant exon • Literature confirms exon is not expressed in tissue of clinical relevance
 AND/OR
• >1 High-quality, high-frequency LoF variant in gnomAD (>0.3%)
Noncoding exon • Exon does not code for protein

gnomAD, Genome Aggregation Database; LoF, loss of function.